{"name": "Fate Therapeutics",
 "permalink": "fate-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/fate-therapeutics",
 "homepage_url": "http://www.fatetherapeutics.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "FateTherapeuti",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Stem Cell Biology Therapeutics",
 "created_at": "Mon Nov 16 19:35:12 UTC 2009",
 "updated_at": "Tue May 21 06:44:41 UTC 2013",
 "overview": "\u003Cp\u003EFounded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. The company has brought together the foremost scientists  from the nation\u00e2\u20ac\u2122s research hotbeds (Boston, San Francisco, San Diego and Seattle) who have demonstrated the potential to create and modulate stem cells to restore health. \u003C/p\u003E\n\n\u003Cp\u003EThe backstory is that while others were working towards therapies based on transplanting stem cell-derived cells into patients, Randall Moon (HHMI and University of Washington) and Alex Rives (Arch Venture Capitol) envisioned a different approach to develop regenerative therapies. The concept, based on data from hematopoietic progenitor cells, was that one could modulate the properties of stem cells in vivo using small molecules or biologics. They presented this idea to Arch Venture Capitol in Seattle, which launched the company, soon to be joined by other investors.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       31],
      "assets/images/resized/0006/6439/66439v2-max-150x150.png"],
     [[250,
       52],
      "assets/images/resized/0006/6439/66439v2-max-250x250.png"],
     [[330,
       69],
      "assets/images/resized/0006/6439/66439v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Vice Chairman",
    "person":
     {"first_name": "John",
      "last_name": "Mendlein",
      "permalink": "john-mendlein",
      "image": null}},
   {"is_past": false,
    "title": "Co-founder",
    "person":
     {"first_name": "Michael",
      "last_name": "Rudnicki",
      "permalink": "michael-rudnicki",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4767/264767v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4767/264767v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4767/264767v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "Len",
      "last_name": "Zon",
      "permalink": "len-zon",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4754/264754v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4754/264754v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4754/264754v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Co-founder",
    "person":
     {"first_name": "Randall",
      "last_name": "Moon",
      "permalink": "randall-moon",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4740/264740v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4740/264740v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4740/264740v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "President and Chief Executive Officer",
    "person":
     {"first_name": "Christian",
      "last_name": "Weyer",
      "permalink": "christian-weyer",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4805/264805v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4805/264805v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4805/264805v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "CTO",
    "person":
     {"first_name": "Dan",
      "last_name": "Shoemaker",
      "permalink": "dan-shoemaker",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4783/264783v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4783/264783v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4783/264783v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "CFO \u0026 Vice President of Operations",
    "person":
     {"first_name": "Scott",
      "last_name": "Wolchko",
      "permalink": "scott-wolchko",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4794/264794v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4794/264794v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4794/264794v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "SVP Clinical Development",
    "person":
     {"first_name": "Pratik",
      "last_name": "Multani",
      "permalink": "pratik-multani",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4789/264789v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4789/264789v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4789/264789v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "Phillip",
      "last_name": "Beachy",
      "permalink": "phillip-beachy",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4748/264748v1-max-150x150.jpg"],
          [[157,
            192],
           "assets/images/resized/0026/4748/264748v1-max-250x250.jpg"],
          [[157,
            192],
           "assets/images/resized/0026/4748/264748v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "Rudolf",
      "last_name": "Jaenisch",
      "permalink": "rudolf-jaenisch",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4779/264779v1-max-150x150.jpg"],
          [[157,
            192],
           "assets/images/resized/0026/4779/264779v1-max-250x250.jpg"],
          [[157,
            192],
           "assets/images/resized/0026/4779/264779v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Director Stem Cell Biology",
    "person":
     {"first_name": "Scott",
      "last_name": "Thies",
      "permalink": "scott-thies",
      "image": null}},
   {"is_past": false,
    "title": "Co-Founder",
    "person":
     {"first_name": "David",
      "last_name": "Scadden",
      "permalink": "david-scadden",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4763/264763v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4763/264763v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4763/264763v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Director of Intellectual Property and Corporate Counsel",
    "person":
     {"first_name": "Cindy",
      "last_name": "Tahl",
      "permalink": "cindy-tahl",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4812/264812v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4812/264812v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4812/264812v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Co-Founder, Founding Etrepreneur",
    "person":
     {"first_name": "Alex",
      "last_name": "Rives",
      "permalink": "alex-rives",
      "image": null}},
   {"is_past": true,
    "title": "Chairman \u0026 Interim CEO",
    "person":
     {"first_name": "William",
      "last_name": "Rastetter",
      "permalink": "william-rastetter",
      "image": null}},
   {"is_past": true,
    "title": "President, CEO",
    "person":
     {"first_name": "Paul",
      "last_name": "Grayson",
      "permalink": "paul-grayson",
      "image": null}},
   {"is_past": true,
    "title": "Senior Director Medicinal Chemisty",
    "person":
     {"first_name": "Francine",
      "last_name": "Farouz",
      "permalink": "francine-farouz",
      "image": null}},
   {"is_past": true,
    "title": "Co-Founder",
    "person":
     {"first_name": "Sheng",
      "last_name": "Ding",
      "permalink": "sheng-ding",
      "image":
       {"available_sizes":
         [[[122,
            150],
           "assets/images/resized/0026/4765/264765v1-max-150x150.png"],
          [[157,
            192],
           "assets/images/resized/0026/4765/264765v1-max-250x250.png"],
          [[157,
            192],
           "assets/images/resized/0026/4765/264765v1-max-450x450.png"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$51.2M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.fatetherapeutics.com/pdf/20091116_PressRelease.pdf",
    "source_description": "Fate Therapetucis",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 11,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "OVP Venture Partners",
         "permalink": "ovp-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               63],
              "assets/images/resized/0003/0402/30402v1-max-150x150.png"],
             [[250,
               106],
              "assets/images/resized/0003/0402/30402v1-max-250x250.png"],
             [[272,
               116],
              "assets/images/resized/0003/0402/30402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Astellas Venture Management",
         "permalink": "astellas-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0004/6637/46637v3-max-150x150.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-250x250.png"],
             [[160,
               64],
              "assets/images/resized/0004/6637/46637v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Genzyme Ventures",
         "permalink": "genzyme-ventures",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0002/8655/28655v1-max-150x150.png"],
             [[155,
               52],
              "assets/images/resized/0002/8655/28655v1-max-250x250.png"],
             [[155,
               52],
              "assets/images/resized/0002/8655/28655v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://seattle.bizjournals.com/seattle/stories/2007/11/26/daily23.html?jst=b_ln_hl",
    "source_description": "Puget Sounds Business Journal",
    "raised_amount": 12000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 11,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Venrock",
         "permalink": "venrock",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0001/6279/16279v1-max-150x150.jpg"],
             [[250,
               87],
              "assets/images/resized/0001/6279/16279v1-max-250x250.jpg"],
             [[351,
               123],
              "assets/images/resized/0001/6279/16279v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OVP Venture Partners",
         "permalink": "ovp-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               63],
              "assets/images/resized/0003/0402/30402v1-max-150x150.png"],
             [[250,
               106],
              "assets/images/resized/0003/0402/30402v1-max-250x250.png"],
             [[272,
               116],
              "assets/images/resized/0003/0402/30402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.nctimes.com/business/biotech-fate-therapeutics-raises-m-for-stem-cell-treatments/article_bd26424c-6dea-5bac-a1f3-9f65e56d46f3.html",
    "source_description": "Fate Therapeutics raises $9.2M for stem cell treatments",
    "raised_amount": 9200000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 8,
    "funded_day": 23,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "10931 North Torrey Pines Road",
    "address2": "Suite 107",
    "zip_code": "92037",
    "city": "La Jolla",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        94],
       "assets/images/resized/0008/0178/80178v1-max-150x150.jpg"],
      [[250,
        157],
       "assets/images/resized/0008/0178/80178v1-max-250x250.jpg"],
      [[450,
        284],
       "assets/images/resized/0008/0178/80178v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}